Fuso Chemical (4368) Q4 2025 earnings summary

Executive summary

• Net sales for FY03/2025 reached a record-high ¥69.5 billion, up 17.9% year-over-year, with operating profit rising 46.4% to ¥16.2 billion and profit attributable to owners increasing 39.3% to ¥11.6 billion.

• EBITDA was ¥24.5 billion, and comprehensive income increased 15.9% to ¥11.4 billion.

• Overseas sales ratio reached 50.6%, reflecting successful global expansion.

Financial highlights

• Gross profit increased to ¥25,971 million, and operating profit margin improved.

• Earnings per share rose 39.3% to ¥329.68.

• Cash and cash equivalents at period end were ¥22.3 billion, with operating cash flows surging to ¥22,701 million.

• Total assets grew to ¥141,502 million, and net assets to ¥104,048 million.

Outlook and guidance

• FY03/2026 net sales are forecast at ¥72.7 billion (+4.6%), with operating profit expected to decline 13.7% to ¥14.0 billion and profit attributable to owners projected at ¥9.4 billion.

• Full-year earnings per share forecast is ¥266.61.

• Moderate recovery anticipated in the semiconductor market, with focus on high-margin products and cost reduction.